美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

VIVUS Inc

0.4665

0.0000

成交量：- -

成交额：- -

市值：833.53万

市盈率：-0.17

高：0.4665

开：0.4665

低：0.4665

收：0.4665

52周最高：4.75

52周最低：0.4369

股本：1,786.77万

流通股本：1,482.35万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.7026

每股收益(LYR):-2.9605

净资产收益率：47.47%

总资产收益率：-2.20%

市净率：-0.11

市盈率(LYR):-0.16

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

VIVUS Inc

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.vivus.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Vivus, Inc.是一家生物制药公司，美国FDA批准两种治疗：Qsymia慢性体重管理和STENDRA勃起功能障碍。 STENDRA也被批准由欧洲委员会，或EC，商品名，SPEDRA，勃起功能障碍在欧盟的治疗。 Qsymia（芬特明和托吡酯缓释）2012年7月被美国FDA批准，作为辅助低热量饮食和增加了慢性体重管理的成人患者体力活动与30或初始体重指数（BMI）更大（肥胖），或27或更大（超重）中的至少一个与体重相关的合并症，如高血压，2型糖尿病或高胆固醇（血脂异常）的存在。 Qsymia采用了专利配方，从两个以前批准的药品，芬特明和托吡酯结合低剂量的活性成分。虽然动作的确切机制是未知的，Qsymia被认为抑制食欲和增加饱腹感，或充满的感觉，这种影响饮食行为的两个主要机制。在2012年9月，通过Qsymia认证送货上门的网络数量有限成为美国市场上。 2013年7月，Qsymia通过约8000沃尔格林，Costco公司成为零售药店提供杜安里德药店nationwide.公司在美国加州于1991年成立并且于1996年重新合并在特拉华州。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/VVUS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"VVUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","market":"US","secType":"STK","nameCN":"VIVUS Inc","latestPrice":0.4665,"timestamp":1594929600000,"preClose":0.4665,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":14823450,"shares":17867697,"eps":-2.702649,"marketStatus":"退市","change":0,"latestTime":"02-20 11:24:33 EST","open":0.4665,"high":0.4665,"low":0.4665,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.702649,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771621200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":765604800000,"exchange":"NASDAQ","adjPreClose":0.4665,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","floatShares":14823450,"roa":"-2.20%","roe":"47.47%","lyrEps":-2.96053,"shares":17867697,"dividePrice":0,"high":0.4665,"amplitude":0,"preClose":0.4665,"low":0.4665,"week52Low":0.4369,"pbRate":"-0.11","week52High":4.75,"institutionHeld":0.1227,"latestPrice":0.4665,"eps":-2.702649,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.702649,"open":0.4665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VVUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-06","symbol":"VVUS","fiscalQuarterEnding":"2020/03","expectedEps":-0.8,"name":null,"time":"盘后","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"post","actualEps":-0.49},{"date":"2020-03-03","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.59,"defaultRemindTime":1583269200000,"name":null,"time":"盘后","dateTimestamp":1583211600000,"actualEps":null},{"date":"2019-11-05","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.62,"defaultRemindTime":1572987600000,"name":null,"time":"盘后","dateTimestamp":1572930000000,"actualEps":null},{"date":"2019-08-06","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-1,"defaultRemindTime":1565121600000,"name":null,"time":"盘后","dateTimestamp":1565064000000,"actualEps":-1.2},{"market":"US","date":"2019-04-30","symbol":"VVUS","fiscalQuarterEnding":"2019/03","expectedEps":-1.17,"name":null,"time":"盘后","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VVUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VVUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VVUS","date":"2020-07-15","current":-0.172608,"percent":0.938697,"low":-1.245839,"twenty":-0.999217,"median":-0.717023,"eighty":-0.611569,"high":-0.284472,"avg":-0.763673,"sd":0.220207,"marketCap":10838545},"quantilePoints":[],"updateTime":1771604673557},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vivus.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vivus, Inc.是一家生物制药公司，美国FDA批准两种治疗：Qsymia慢性体重管理和STENDRA勃起功能障碍。 STENDRA也被批准由欧洲委员会，或EC，商品名，SPEDRA，勃起功能障碍在欧盟的治疗。 Qsymia（芬特明和托吡酯缓释）2012年7月被美国FDA批准，作为辅助低热量饮食和增加了慢性体重管理的成人患者体力活动与30或初始体重指数（BMI）更大（肥胖），或27或更大（超重）中的至少一个与体重相关的合并症，如高血压，2型糖尿病或高胆固醇（血脂异常）的存在。 Qsymia采用了专利配方，从两个以前批准的药品，芬特明和托吡酯结合低剂量的活性成分。虽然动作的确切机制是未知的，Qsymia被认为抑制食欲和增加饱腹感，或充满的感觉，这种影响饮食行为的两个主要机制。在2012年9月，通过Qsymia认证送货上门的网络数量有限成为美国市场上。 2013年7月，Qsymia通过约8000沃尔格林，Costco公司成为零售药店提供杜安里德药店nationwide.公司在美国加州于1991年成立并且于1996年重新合并在特拉华州。","exchange":"NASDAQ","name":"VIVUS Inc","nameEN":"VIVUS Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":null}}